Lv7
3760 积分 2022-02-18 加入
Izalontamab brengitecan (Iza-bren; BL-B01D1), a first-in-class EGFR-HER3 bispecific antibody–drug conjugate, for patients with EGFR-mutated NSCLC: pooled analysis of phase I and phase II trials
4天前
已完结
Antibody–drug conjugates: a practical review on clinical management of toxicities
4天前
已完结
Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale
4天前
已完结
Design, Synthesis, and Biological Evaluation of Evodiamine Derivatives as Antibody–Drug Conjugate Payloads
9天前
已完结
Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability
9天前
已完结
β-glucuronidase-triggered ortho-hydroxyl-mediated cyclization strategy for the efficient delivery of phenolic payloads in antibody-drug conjugates
11天前
已完结
General chemoselective hindered amide coupling enabled by TCFH-catalytic Oxyma and transient imine protection
12天前
已完结
N-myristoyltransferases: structure, function, disease, and inhibitors
16天前
已完结
Synthesis and biological evaluation of cyanoguanidine derivatives of loratadine
16天前
已完结
Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations
18天前
已完结
皖公网安备34019202002308
